# Roche’s GLP-1/GIP drug hits in phase 2 diabetes trial, fueling best-in-disease hopes

> **Newsylist Open Intelligence Dossier** · First detected: 2026-09-23 01:29 UTC · Category: Business · Sources: 2 · Current Velocity: 0.71

## Key People, Organizations & Locations
GLP-1, Roche, GIP

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| qz.com | Roche obesity and diabetes drug enicepatide Phase 2 trial results | 2026-09-22 09:20 | [Source Link](https://news.google.com/rss/articles/CBMihAFBVV95cUxPeUR0WHE4OHA1dF9NMXBMZklLOUFuelNteWI2TFZXMmFsWElHcXJVVW5xX05FQVNHSGlkeTJNWnJvbVdXeFlXYUljemgweTMxZTdUVzNnajVzQU90ZHZLSnoxVW9mN0g3TkZEWFdJblFsbG84Yk1Pem9SRFpnVGxOejdvSzU?oc=5) |
| yahoo.com | Roche’s acquired GLP-1/GIP normalises blood sugar in Phase II trial | 2026-09-22 09:20 | [Source Link](https://news.google.com/rss/articles/CBMiiwFBVV95cUxPWjNORjl4T2RjcDhTSll0OGhPMmJrZUhBRkFpaVA4OXg3aTJfTERYWmJfUVBUbVBlakIycFlpMllIek9WTEpwQWtVcURaOWQ1OFhsbXdxNzJfXzdXZktkNlV3OWkyaFFmWW4zMHZXQ05lTktJdjVnNTl0NkVEVHRCYWlNakJFU1o4M2JR?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-09-23/roche-s-glp-1-gip-drug-hits-in-phase-2-diabetes-trial-fueling-best-in-disease*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*